This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Bernstein Keeps Their Buy Rating on Cigna (CI)

Tipranks - Tipranks - Thu May 28, 6:04AM CDT

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Cigna, with a price target of $371.00.

Memorial Day Sale – Claim 70% Off TipRanks

According to TipRanks, Wilkes is a 4-star analyst with an average return of 7.9% and a 59.65% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as CVS Health, Cigna, and HCA Healthcare.

In addition to Bernstein, Cigna also received a Buy from UBS’s A.J. Rice in a report issued on May 22. However, yesterday, Barclays downgraded Cigna (NYSE: CI) to a Hold.

See Insiders’ Hot Stocks on TipRanks >>

Based on Cigna’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $68.49 billion and a net profit of $1.65 billion. In comparison, last year the company earned a revenue of $65.5 billion and had a net profit of $1.32 billion

Read More on CI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).